134 related articles for article (PubMed ID: 17327350)
21. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
[TBL] [Abstract][Full Text] [Related]
22. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
23. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Kang SW; Park SC; Cho HY; Kang JH
Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
[TBL] [Abstract][Full Text] [Related]
24. Vision-related quality of life in patients with diabetic macular oedema.
Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
[TBL] [Abstract][Full Text] [Related]
25. [The effect of the vitreal adherence in the macular region in diabetic maculopathy course based on FA picture in patients with type 2 of diabetes mellitus].
Kwiecień S; Szaflik J
Klin Oczna; 2007; 109(4-6):160-4. PubMed ID: 17725276
[TBL] [Abstract][Full Text] [Related]
26. Ophthaproblem. Diabetic macular edema.
Sharma S
Can Fam Physician; 1998 Jan; 44():42, 50. PubMed ID: 9481459
[No Abstract] [Full Text] [Related]
27. Decreased vitreal hyaluronan levels with aging.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
[TBL] [Abstract][Full Text] [Related]
28. DRCR Study: outcomes in focal vs diffuse edema?
Blanco-Garavito R; Rodriguez-Valdes PJ
Ophthalmology; 2009 Mar; 116(3):595-6; author reply 596-7. PubMed ID: 19264221
[No Abstract] [Full Text] [Related]
29. Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy.
Reverter JL; Nadal J; Fernández-Novell JM; Ballester J; Ramió-Lluch L; Rivera MM; Elizalde J; Abengoechea S; Guinovart JJ; Rodríguez-Gil JE
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1378-82. PubMed ID: 18978347
[TBL] [Abstract][Full Text] [Related]
30. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
31. OCT vitreoretinal interface patterns.
Thomas D; Laidlaw DA
Eye (Lond); 2003 May; 17(4):541-2. PubMed ID: 12802365
[No Abstract] [Full Text] [Related]
32. Transthyretin levels in the vitreous correlate with change in visual acuity after vitrectomy.
Van Aken E; De Letter EA; Veckeneer M; Derycke L; van Enschot T; Geers I; Delanghe S; Delanghe JR
Br J Ophthalmol; 2009 Nov; 93(11):1539-45. PubMed ID: 19692381
[TBL] [Abstract][Full Text] [Related]
33. [Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy].
Asensio-Sánchez VM; Gómez-Ramírez V; Morales-Gómez I
Arch Soc Esp Oftalmol; 2008 Mar; 83(3):169-72. PubMed ID: 18311675
[TBL] [Abstract][Full Text] [Related]
34. Vitrectomy and lens status.
Kim SJ; Lo WR; Srivastava SK
Ophthalmology; 2008 Feb; 115(2):415; author reply 415-6. PubMed ID: 18243917
[No Abstract] [Full Text] [Related]
35. Macular edema in unregulated type 2 diabetic patients following glycemic control.
Kayýkçýolu O; Ozmen B; Seymenoglu G; Tunali D; Kafesçiler SO; Güclü F; Hekimsoy Z
Arch Med Res; 2007 May; 38(4):398-402. PubMed ID: 17416286
[TBL] [Abstract][Full Text] [Related]
36. Diabetic retinopathy: more patients, less laser: a longitudinal population-based study in Tayside, Scotland.
Vallance JH; Wilson PJ; Leese GP; McAlpine R; MacEwen CJ; Ellis JD
Diabetes Care; 2008 Jun; 31(6):1126-31. PubMed ID: 18346993
[TBL] [Abstract][Full Text] [Related]
37. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
38. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
39. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
Merlak M; Kovacević D; Balog T; Marotti T; Misljenović T; Mikulicić M; Dekaris I
Coll Antropol; 2008 Oct; 32 Suppl 2():39-43. PubMed ID: 19138004
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
